Amgen Inc. (AMGN.TO)
Stock analysis · TSX · Healthcare · Drug Manufacturers - General
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
1.51
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A
Amgen Inc. (AMGN.TO) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About Amgen Inc.
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap